Anaesthetic-Related Neuroprotection: Intravenous or Inhalational Agents?

ISSN： 1172-7047

Source： CNS Drugs, Vol.24, Iss.11, 2010-11, pp. : 893-907

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intravenous/Oral Sequential Therapy in Patients Hospitalised with Community-Acquired Pneumonia: Which Patients, When and What Agents?

By Vogel F.

Drugs, Vol. 62, Iss. 2, 2002-01 ,pp. : 309-317

Adis International

Access to resources Recommend Favorite

PAR2 antagonists: anti-inflammatory agents?

Inpharma, Vol. 1, Iss. 1226, 2000-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Can statins operate as neuroprotective agents?

Inpharma, Vol. 1, Iss. 1305, 2001-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Newer Neuromuscular Blocking Agents: How do They Compare with Established Agents?

By Sparr H.J.

Drugs, Vol. 61, Iss. 7, 2001-01 ,pp. : 919-942

Adis International

Access to resources Recommend Favorite

Lung Surfactants for Neonatal Respiratory Distress Syndrome: Animal-Derived or Synthetic Agents?

By Suresh G.K. Soll R.F.

Pediatric Drugs, Vol. 4, Iss. 8, 2002-01 ,pp. : 485-492

Adis International

Access to resources Recommend Favorite